JP2025512574A5 - - Google Patents
Info
- Publication number
- JP2025512574A5 JP2025512574A5 JP2024562060A JP2024562060A JP2025512574A5 JP 2025512574 A5 JP2025512574 A5 JP 2025512574A5 JP 2024562060 A JP2024562060 A JP 2024562060A JP 2024562060 A JP2024562060 A JP 2024562060A JP 2025512574 A5 JP2025512574 A5 JP 2025512574A5
- Authority
- JP
- Japan
- Prior art keywords
- promoter
- vector
- bag3
- polynucleotide
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263333798P | 2022-04-22 | 2022-04-22 | |
| US63/333,798 | 2022-04-22 | ||
| PCT/US2023/066054 WO2023205767A2 (en) | 2022-04-22 | 2023-04-21 | B-cell lymphoma 2–associated anthanogene 3 (bag3) gene therapy using aav vector |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512574A JP2025512574A (ja) | 2025-04-17 |
| JP2025512574A5 true JP2025512574A5 (enExample) | 2026-04-22 |
Family
ID=88420755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562060A Pending JP2025512574A (ja) | 2022-04-22 | 2023-04-21 | ＡＡＶベクターを使用するＢ細胞リンパ腫２関連Ａｎｔｈａｎｏｇｅｎｅ ３ （ＢＡＧ３）遺伝子治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20250269065A1 (enExample) |
| EP (1) | EP4511048A2 (enExample) |
| JP (1) | JP2025512574A (enExample) |
| KR (1) | KR20250012749A (enExample) |
| CN (1) | CN119072323A (enExample) |
| AR (1) | AR129122A1 (enExample) |
| AU (1) | AU2023258039A1 (enExample) |
| CA (1) | CA3248774A1 (enExample) |
| CL (1) | CL2024003182A1 (enExample) |
| IL (1) | IL316183A (enExample) |
| MX (1) | MX2024012761A (enExample) |
| TW (1) | TW202409285A (enExample) |
| WO (1) | WO2023205767A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE055862T2 (hu) | 2016-04-20 | 2021-12-28 | Centro De Investig Energeticas | Készítmények és eljárások PKLR fokozott génexpressziójára |
| SG11202002263TA (en) | 2017-10-16 | 2020-04-29 | Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas | Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency |
| WO2019200167A1 (en) | 2018-04-11 | 2019-10-17 | Rocket Pharmaceuticals, Ltd. | Compositions and methods for stem cell transplant |
| WO2024215655A1 (en) * | 2023-04-10 | 2024-10-17 | Tenaya Therapeutics, Inc. | Cardioprotective bag3 therapies |
| WO2024229259A1 (en) * | 2023-05-02 | 2024-11-07 | Research Institute At Nationwide Children's Hospital | Gene therapy for treatment of protein misfolding diseases |
| WO2025235491A1 (en) * | 2024-05-07 | 2025-11-13 | Affinia Therapeutics Inc. | Recombinant aav for treatment of cardiac diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2650507A1 (en) * | 2006-04-27 | 2007-11-08 | Universite De Montreal | Assessment and reduction of risk of graft-versus-host disease |
| WO2015117010A2 (en) * | 2014-01-31 | 2015-08-06 | Temple University Of The Commonwealth System Of Higher Education | Bag3 as a target for therapy of heart failure |
| EP4081643A1 (en) * | 2019-12-24 | 2022-11-02 | Asklepios Biopharmaceutical, Inc. | Regulatory nucleic acid sequences |
-
2023
- 2023-04-21 KR KR1020247037769A patent/KR20250012749A/ko active Pending
- 2023-04-21 AU AU2023258039A patent/AU2023258039A1/en active Pending
- 2023-04-21 WO PCT/US2023/066054 patent/WO2023205767A2/en not_active Ceased
- 2023-04-21 TW TW112115006A patent/TW202409285A/zh unknown
- 2023-04-21 US US18/858,272 patent/US20250269065A1/en active Pending
- 2023-04-21 JP JP2024562060A patent/JP2025512574A/ja active Pending
- 2023-04-21 CN CN202380035629.7A patent/CN119072323A/zh active Pending
- 2023-04-21 IL IL316183A patent/IL316183A/en unknown
- 2023-04-21 AR ARP230100975A patent/AR129122A1/es unknown
- 2023-04-21 EP EP23792804.9A patent/EP4511048A2/en active Pending
- 2023-04-21 CA CA3248774A patent/CA3248774A1/en active Pending
-
2024
- 2024-10-15 MX MX2024012761A patent/MX2024012761A/es unknown
- 2024-10-17 CL CL2024003182A patent/CL2024003182A1/es unknown